Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 127

1.

Sedentary lifestyle in middle-aged women is associated with severe menopausal symptoms and obesity.

Blümel JE, Fica J, Chedraui P, Mezones-Holguín E, Zuñiga MC, Witis S, Vallejo MS, Tserotas K, Sánchez H, Onatra W, Ojeda E, Mostajo D, Monterrosa A, Lima S, Martino M, Hernández-Bueno JA, Gómez G, Espinoza MT, Flores D, Calle A, Bravo LM, Benítez Z, Bencosme A, Barón G, Aedo S; Collaborative Group for Research of the Climacteric in Latin America.

Menopause. 2016 Jan 19. [Epub ahead of print]

PMID:
26818013
2.

Perinatal outcome in singleton pregnancies complicated with preeclampsia and eclampsia in Ecuador.

Phoa KY, Chedraui P, Pérez-López FR, Wendte JF, Ghiabi S, Vrijkotte T, Pinto P.

J Obstet Gynaecol. 2016 Jan 20:1-4. [Epub ahead of print]

PMID:
26790539
3.

Reply to the Letter to the Editor: A rebuttal: FSFI questionnaire does not assess female sexual function, by V. Puppo and G. Puppo: Sexual function: From pulp fiction to evidence-based screening.

Pérez-López FR, Chedraui P.

Maturitas. 2016 Jan;83:95-6. doi: 10.1016/j.maturitas.2015.09.006. Epub 2015 Sep 30. No abstract available.

PMID:
26481142
4.

Assessing sexual problems in women at midlife using the short version of the female sexual function index.

Chedraui P, Pérez-López FR.

Maturitas. 2015 Nov;82(3):299-303. doi: 10.1016/j.maturitas.2015.07.005. Epub 2015 Jul 14. Review.

PMID:
26323235
5.

Assessment of obstructive sleep apnea-hypopnea syndrome risk at the end of pregnancy using the Berlin Questionnaire.

Fernández Alonso AM, Chedraui P, Pérez-López FR.

Gynecol Endocrinol. 2015;31(9):715-9. doi: 10.3109/09513590.2015.1034099. Epub 2015 Aug 17.

PMID:
26291810
6.

Red clover isoflavone metabolite bioavailability is decreased after fructooligosaccharide supplementation.

Lipovac M, Pfitscher A, Hobiger S, Laschitz T, Imhof M, Chedraui P, Jungbauer A.

Fitoterapia. 2015 Sep;105:93-101. doi: 10.1016/j.fitote.2015.06.011. Epub 2015 Jun 11.

PMID:
26073948
7.

Treatment of menopausal symptoms with three low-dose continuous sequential 17β-estradiol/progesterone parenteral monthly formulations using novel non-polymeric microsphere technology.

Cortés-Bonilla M, Bernardo-Escudero R, Alonso-Campero R, Francisco-Doce MT, Hernández-Valencia M, Celis-González C, Márquez-Oñate R, Chedraui P, Uribe JA.

Gynecol Endocrinol. 2015 Jul;31(7):552-9. doi: 10.3109/09513590.2015.1019853. Epub 2015 Jun 10.

PMID:
26062108
8.

Polymorphisms of the methylenetetrahydrofolate reductase gene (C677T and A1298C) in the placenta of pregnancies complicated with preeclampsia.

Chedraui P, Andrade ME, Salazar-Pousada D, Escobar GS, Hidalgo L, Ramirez C, Spaanderman ME, Kramer BW, Gavilanes AW.

Gynecol Endocrinol. 2015 Jul;31(7):569-72. doi: 10.3109/09513590.2015.1031104. Epub 2015 Jun 2.

PMID:
26036716
9.

Women's Health Initiative estrogen plus progestin clinical trial: a study that does not allow establishing relevant clinical risks.

Aedo S, Cavada G, Blümel JE, Chedraui P, Fica J, Barriga P, Brantes S, Irribarra C, Vallejo M, Campodónico Í.

Menopause. 2015 Dec;22(12):1317-22. doi: 10.1097/GME.0000000000000472.

PMID:
25968833
10.

Umbilical cord plasma interferon-induced protein 10 (IP-10) and interferon-induced T-cell alpha chemoattractant (ITAC) levels are lower in women with severe preeclampsia.

Chedraui P, Solís EJ, Pérez-López FR, Schatz F, Kayisli U, Escobar GS, Loja-Chango R, Hidalgo L, Lockwood CJ.

J Perinat Med. 2015 Mar 4. pii: /j/jpme.ahead-of-print/jpm-2014-0371/jpm-2014-0371.xml. doi: 10.1515/jpm-2014-0371. [Epub ahead of print]

PMID:
25741937
11.

Obesity and its relation to depressive symptoms and sedentary lifestyle in middle-aged women.

Blümel JE, Chedraui P, Aedo S, Fica J, Mezones-Holguín E, Barón G, Bencosme A, Benítez Z, Bravo LM, Calle A, Flores D, Espinoza MT, Gómez G, Hernández-Bueno JA, Laribezcoa F, Martino M, Lima S, Monterrosa A, Mostajo D, Ojeda E, Onatra W, Sánchez H, Tserotas K, Vallejo MS, Witis S, Zúñiga MC.

Maturitas. 2015 Jan;80(1):100-5. doi: 10.1016/j.maturitas.2014.10.007. Epub 2014 Oct 23.

PMID:
25459364
12.

Evaluation of the presence and severity of menopausal symptoms among postmenopausal women screened for the metabolic syndrome.

Chedraui P, Pérez-López FR, Hidalgo L, Villacreses D, Domínguez A, Escobar GS, Genazzani AR, Simoncini T; Research Group for the Omega Women’s Health Project.

Gynecol Endocrinol. 2014 Sep 25;30(12):918-24. doi: 10.3109/09513590.2014.971236. Epub 2014 Oct 27.

PMID:
25347000
13.

[Maternal and perinatal outcomes in nulliparous gestations with late onset preeclampsia: Comparative study with gestations without preeclampsia].

Salazar-Pousada D, Chedraui P, Villao A, Pérez-Roncero GR, Hidalgo L.

Enferm Clin. 2014 Nov-Dec;24(6):345-50. doi: 10.1016/j.enfcli.2014.05.001. Epub 2014 Aug 6. Spanish.

PMID:
25107334
14.

Application of the 10-item Cervantes Scale among mid-aged Ecuadorian women for the assessment of menopausal symptoms.

Chedraui P, Pérez-López FR, Sánchez H, Sánchez P, Miranda O, Quispe P, Madero-Trelles T, Hidalgo L, Arboleda D, López G, Quintero JC.

Maturitas. 2014 Sep;79(1):100-5. doi: 10.1016/j.maturitas.2014.06.019. Epub 2014 Jul 6.

PMID:
25085706
15.

Circulating leptin, resistin, adiponectin, visfatin, adipsin and ghrelin levels and insulin resistance in postmenopausal women with and without the metabolic syndrome.

Chedraui P, Pérez-López FR, Escobar GS, Palla G, Montt-Guevara M, Cecchi E, Genazzani AR, Simoncini T; Research Group for the Omega Women's Health Project.

Maturitas. 2014 Sep;79(1):86-90. doi: 10.1016/j.maturitas.2014.06.008. Epub 2014 Jun 18.

PMID:
25015014
16.

Polymorphisms of the methylenetetrahydrofolate reductase gene (C677T and A1298C) in nulliparous women complicated with preeclampsia.

Chedraui P, Salazar-Pousada D, Villao A, Escobar GS, Ramirez C, Hidalgo L, Pérez-López FR, Genazzani A, Simoncini T.

Gynecol Endocrinol. 2014 May;30(5):392-6. doi: 10.3109/09513590.2014.895807. Epub 2014 Mar 10.

PMID:
24611473
17.

Angiogenesis, inflammation and endothelial function in postmenopausal women screened for the metabolic syndrome.

Chedraui P, Escobar GS, Pérez-López FR, Palla G, Montt-Guevara M, Cecchi E, Genazzani AR, Simoncini T; Research Group for the Omega Women's Health Project.

Maturitas. 2014 Apr;77(4):370-4. doi: 10.1016/j.maturitas.2014.01.014. Epub 2014 Feb 7.

PMID:
24598235
18.

Assessment of subjective sleep disturbance and related factors during female mid-life with the Jenkins Sleep Scale.

Ornat L, Martínez-Dearth R, Chedraui P, Pérez-López FR.

Maturitas. 2014 Apr;77(4):344-50. doi: 10.1016/j.maturitas.2014.01.005. Epub 2014 Jan 24.

PMID:
24529826
19.

A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI).

Blümel JE, Chedraui P, Barón G, Benítez Z, Flores D, Espinoza MT, Gomez G, González E, Hernández L, Lima S, Martino M, Montaño A, Monterrosa A, Mostajo D, Ojeda E, Onatra W, Robles C, Saavedra J, Sánchez H, Tserotas K, Vallejo MS, Vallejo C; Collaborative Group for Research of the Climacteric in Latin America (REDLINC).

Climacteric. 2014 Aug;17(4):433-41. doi: 10.3109/13697137.2014.882305. Epub 2014 Jan 29.

PMID:
24443950
20.

Assessment of menopause-related symptoms in mid-aged women with the 10-item Cervantes Scale.

Pérez-López FR, Fernández-Alonso AM, Pérez-Roncero G, Chedraui P, Monterrosa-Castro A, Llaneza P.

Maturitas. 2013 Oct;76(2):151-4. doi: 10.1016/j.maturitas.2013.07.002. Epub 2013 Aug 1.

PMID:
23916081
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk